Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Forward Modeling of Coronal Mass Ejection Flux Ropes in the Inner Heliosphere with 3DCORE.

Möstl C, Amerstorfer T, Palmerio E, Isavnin A, Farrugia CJ, Lowder C, Winslow RM, Donnerer JM, Kilpua EKJ, Boakes PD.

Space Weather. 2018 Mar;16(3):216-229. doi: 10.1002/2017SW001735. Epub 2018 Mar 7.

2.

Modeling observations of solar coronal mass ejections with heliospheric imagers verified with the Heliophysics System Observatory.

Möstl C, Isavnin A, Boakes PD, Kilpua EKJ, Davies JA, Harrison RA, Barnes D, Krupar V, Eastwood JP, Good SW, Forsyth RJ, Bothmer V, Reiss MA, Amerstorfer T, Winslow RM, Anderson BJ, Philpott LC, Rodriguez L, Rouillard AP, Gallagher P, Nieves-Chinchilla T, Zhang TL.

Space Weather. 2017 Jul;15(7):955-970. doi: 10.1002/2017SW001614. Epub 2017 Jul 29.

3.

Factors Affecting the Geo-effectiveness of Shocks and Sheaths at 1 AU.

Lugaz N, Farrugia CJ, Winslow RM, Al-Haddad N, Kilpua EKJ, Riley P.

J Geophys Res Space Phys. 2016 Nov;121(11):10861-10879. doi: 10.1002/2016JA023100. Epub 2016 Oct 29.

4.

Earth's magnetosphere and outer radiation belt under sub-Alfvénic solar wind.

Lugaz N, Farrugia CJ, Huang CL, Winslow RM, Spence HE, Schwadron NA.

Nat Commun. 2016 Oct 3;7:13001. doi: 10.1038/ncomms13001.

5.

Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia.

Tsai AG, Cabrales P, Young MA, Winslow RM, Intaglietta M.

Artif Cells Nanomed Biotechnol. 2015 Feb;43(1):10-7. doi: 10.3109/21691401.2014.936063. Epub 2014 Jul 25.

PMID:
25060721
6.

Addiction in Singapore: changing patterns and evolving challenges.

Peh AL, Lim YC, Winslow RM.

Singapore Med J. 2012 Jul;53(7):435-7; quiz 438. Review.

7.

Oxygen: the poison is in the dose.

Winslow RM.

Transfusion. 2013 Feb;53(2):424-37. doi: 10.1111/j.1537-2995.2012.03774.x. Epub 2012 Jul 15. Review.

PMID:
22804568
8.

Qualities of a psychiatric mentor: a quantitative Singaporean survey.

Tor PC, Goh LG, Ang YG, Lim L, Winslow RM, Ng BY, Wong ST, Ng TP, Kia EH.

Acad Psychiatry. 2011 Nov 1;35(6):407-10. doi: 10.1176/appi.ap.35.6.407.

PMID:
22193742
9.

The global magnetic field of Mercury from MESSENGER orbital observations.

Anderson BJ, Johnson CL, Korth H, Purucker ME, Winslow RM, Slavin JA, Solomon SC, McNutt RL Jr, Raines JM, Zurbuchen TH.

Science. 2011 Sep 30;333(6051):1859-62. doi: 10.1126/science.1211001.

10.

Hemospan: design principles for a new class of oxygen therapeutic.

Vandegriff KD, Winslow RM.

Artif Organs. 2009 Feb;33(2):133-8. doi: 10.1111/j.1525-1594.2008.00697.x.

PMID:
19178457
11.

Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch.

Young MA, Lohman J, Malavalli A, Vandegriff KD, Winslow RM.

J Cardiothorac Vasc Anesth. 2009 Jun;23(3):339-47. doi: 10.1053/j.jvca.2008.08.006. Epub 2008 Oct 22.

PMID:
18948027
12.

Sites of modification of hemospan, a poly(ethylene glycol)-modified human hemoglobin for use as an oxygen therapeutic.

Vandegriff KD, Malavalli A, Mkrtchyan GM, Spann SN, Baker DA, Winslow RM.

Bioconjug Chem. 2008 Nov 19;19(11):2163-70. doi: 10.1021/bc8002666.

PMID:
18837531
13.

Hemoglobin-based blood substitutes and risk of myocardial infarction and death.

Keipert PE, Olofsson C, Winslow RM.

JAMA. 2008 Sep 17;300(11):1295-6; author reply 1298-9. doi: 10.1001/jama.300.11.1295-b. No abstract available.

PMID:
18799435
14.

Cell-free oxygen carriers: scientific foundations, clinical development, and new directions.

Winslow RM.

Biochim Biophys Acta. 2008 Oct;1784(10):1382-6. doi: 10.1016/j.bbapap.2008.04.032. Epub 2008 May 21. Review.

PMID:
18555029
15.

CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.

Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, Winslow RM.

Br J Pharmacol. 2008 Aug;154(8):1649-61. doi: 10.1038/bjp.2008.219. Epub 2008 Jun 9.

16.

Red cell age and loss of function: advance or SNO-job?

Winslow RM, Intaglietta M.

Transfusion. 2008 Mar;48(3):411-4. doi: 10.1111/j.1537-2995.2008.01657.x. No abstract available.

PMID:
18302664
17.

A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia.

Olofsson C, Nygårds EB, Ponzer S, Fagrell B, Przybelski R, Keipert PE, Winslow N, Winslow RM.

Transfus Med. 2008 Feb;18(1):28-39. doi: 10.1111/j.1365-3148.2007.00811.x.

PMID:
18279190
18.
19.

Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic.

Svergun DI, Ekström F, Vandegriff KD, Malavalli A, Baker DA, Nilsson C, Winslow RM.

Biophys J. 2008 Jan 1;94(1):173-81. Epub 2007 Sep 7.

20.

Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys.

Young MA, Malavalli A, Winslow N, Vandegriff KD, Winslow RM.

Transl Res. 2007 Jun;149(6):333-42. Epub 2007 May 23.

PMID:
17543852
21.

The role of hemoglobin oxygen affinity in oxygen transport at high altitude.

Winslow RM.

Respir Physiol Neurobiol. 2007 Sep 30;158(2-3):121-7. Epub 2007 Mar 24. Review.

PMID:
17449336
22.

A quantitative framework for the design of acellular hemoglobins as blood substitutes: implications of dynamic flow conditions.

Cole RH, Vandegriff KD, Szeri AJ, Savaş O, Baker DA, Winslow RM.

Biophys Chem. 2007 Jun;128(1):63-74. Epub 2007 Mar 13.

23.

Red cell substitutes.

Winslow RM.

Semin Hematol. 2007 Jan;44(1):51-9. Review.

PMID:
17198847
24.

A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgery.

Olofsson C, Ahl T, Johansson T, Larsson S, Nellgård P, Ponzer S, Fagrell B, Przybelski R, Keipert P, Winslow N, Winslow RM.

Anesthesiology. 2006 Dec;105(6):1153-63.

PMID:
17122578
25.

Current status of oxygen carriers ('blood substitutes'): 2006.

Winslow RM.

Vox Sang. 2006 Aug;91(2):102-10. Review.

PMID:
16907870
26.

Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers.

Tsai AG, Cabrales P, Manjula BN, Acharya SA, Winslow RM, Intaglietta M.

Blood. 2006 Nov 15;108(10):3603-10. Epub 2006 Jul 20.

27.

Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates.

Vandegriff KD, Malavalli A, Minn C, Jiang E, Lohman J, Young MA, Samaja M, Winslow RM.

Biochem J. 2006 Nov 1;399(3):463-71.

28.

Blood substitutes: a review of the literature 1997-1998.

Winslow RM.

IDrugs. 1999 Apr;2(4):340-54.

PMID:
16158353
29.

Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensive.

Acharya SA, Friedman JM, Manjula BN, Intaglietta M, Tsai AG, Winslow RM, Malavalli A, Vandegriff K, Smith PK.

Artif Cells Blood Substit Immobil Biotechnol. 2005;33(3):239-55.

PMID:
16152690
30.

MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine.

Young MA, Riddez L, Kjellström BT, Bursell J, Winslow F, Lohman J, Winslow RM.

Crit Care Med. 2005 Aug;33(8):1794-804.

PMID:
16096458
31.

Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin.

Cabrales P, Tsai AG, Winslow RM, Intaglietta M.

Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2392-400. Epub 2005 Jul 15.

32.

To publish or not to publish.

Winslow RM.

J Lab Clin Med. 2005 Apr;145(4):221; discussion 222. No abstract available.

PMID:
15962841
33.

A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol.

Björkholm M, Fagrell B, Przybelski R, Winslow N, Young M, Winslow RM.

Haematologica. 2005 Apr;90(4):505-15.

34.

Targeted O2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers.

Winslow RM.

Artif Cells Blood Substit Immobil Biotechnol. 2005;33(1):1-12. Review.

PMID:
15768561
35.

Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressure.

Cabrales P, Tsai AG, Winslow RM, Intaglietta M.

Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2146-53. Epub 2005 Jan 6.

36.

Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin.

Wettstein R, Cabrales P, Erni D, Tsai AG, Winslow RM, Intaglietta M.

Shock. 2004 Oct;22(4):351-7.

PMID:
15377891
37.

MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugate.

Winslow RM.

Artif Organs. 2004 Sep;28(9):800-6. Review.

PMID:
15320943
38.

Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat.

Winslow RM, Lohman J, Malavalli A, Vandegriff KD.

J Appl Physiol (1985). 2004 Oct;97(4):1527-34. Epub 2004 Jun 18.

39.

WITHDRAWN: PEGylated hemoglobin: Role of surface configuration of PEG for the modulation of hemoglobin vasoactivity.

Manjula BN, Tsai AG, Intaglietta M, Tsai CH, Ho C, Malavalli A, Vandegriff KD, Winslow RM, Smith PK, Perumalsamy K, Devi Kanika N, Friedman JM, Acharya SA.

J Biol Chem. 2004 Aug 27. [Epub ahead of print]

40.

Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin.

Vandegriff KD, Bellelli A, Samaja M, Malavalli A, Brunori M, Winslow RM.

Biochem J. 2004 Aug 15;382(Pt 1):183-9.

41.

Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4).

Drobin D, Kjellstrom BT, Malm E, Malavalli A, Lohman J, Vandegriff KD, Young MA, Winslow RM.

J Appl Physiol (1985). 2004 May;96(5):1843-53. Epub 2004 Jan 16.

42.

Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.

Winslow RM.

Curr Hematol Rep. 2003 Nov;2(6):503-10. Review.

PMID:
14561395
43.

Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia.

Tsai AG, Cabrales P, Winslow RM, Intaglietta M.

Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1537-45. Epub 2003 Jun 12.

44.

Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics.

Tsai AG, Vandegriff KD, Intaglietta M, Winslow RM.

Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1411-9. Epub 2003 Jun 12.

45.
46.

Current status of blood substitute research: towards a new paradigm.

Winslow RM.

J Intern Med. 2003 May;253(5):508-17. Review.

47.

MP4, a new nonvasoactive PEG-Hb conjugate.

Vandegriff KD, Malavalli A, Wooldridge J, Lohman J, Winslow RM.

Transfusion. 2003 Apr;43(4):509-16.

PMID:
12662285
48.

Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain.

Manjula BN, Tsai A, Upadhya R, Perumalsamy K, Smith PK, Malavalli A, Vandegriff K, Winslow RM, Intaglietta M, Prabhakaran M, Friedman JM, Acharya AS.

Bioconjug Chem. 2003 Mar-Apr;14(2):464-72.

PMID:
12643758
49.

Blood substitutes.

Winslow RM.

Curr Opin Hematol. 2002 Mar;9(2):146-51. Review.

PMID:
11844999
50.

Supplemental Content

Loading ...
Support Center